As CEO, Dan drives the overall strategic vision for PanGenX. Dan is well known for his strategic insight in personalized medicine and provided consulting to leading therapeutic, diagnostic and health IT companies. Prior to founding PanGenX, Dan was a consultant at Third Rock Ventures, where he focused on establishing novel personalized medicine companies. Also, as a co-founder at Scientia, he led and managed a variety of functions for numerous li

Dr. Neumann, a graduate from MIT, is a recognized expert in Semantic Information Systems, and has worked on numerous information initiatives for the pharmaceutical and life sciences. He has founded and chaired the W3C Semantic Web Healthcare and Life Science Interest Group, which brings together many industry leaders to advance standards. Dr. Neumann is also the Executive Director and Founder of the Clinical Semantics Group, a consulting firm

Barry P. Chaiken, MD, MPH, FHIMSS has over 20 years experience in healthcare information technology, patient safety, clinical transformation, and public health. He previously worked with the National Institutes of Health, U.K’s. National Health Service, McKesson, and BearingPoint. Chaiken served as a Board member (2006-2010), Board Liaison to HIMSS Europe (2006-2009), and Board Chair (2009-2010), and continues his involvement as a Fellow of the H

David, a driving force in the financial industry, has operated his own consulting firm providing executive services, specializing in interim executive management, IPOS, turnarounds, strategic analysis, and mergers and acquisitions, over the last 18 years. Previous clients include Stromedix, where as CFO, David helped the company complete its $500+ Million acquisition by Biogen. GlycoFi, where as CFO, David helped the company complete its $400+